Shopping Cart
- Remove All
- Your shopping cart is currently empty
ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $42 | In Stock | |
5 mg | $93 | In Stock | |
10 mg | $133 | In Stock | |
25 mg | $223 | In Stock | |
50 mg | $392 | In Stock | |
100 mg | $668 | In Stock | |
500 mg | $2,530 | In Stock |
Description | ADT-007 is an orally active and selective pan-RAS inhibitor with potent anticancer activity.ADT-007 blocks GTP activation of RAS and MAPK/AKT signaling by binding to anucleotide RAS.ADT-007 is used in the study of gastrointestinal cancers. |
In vivo | In 6-8-week-old BALB/C mice injected with colorectal cancer cells, ADT-007 (10 mg/kg; intra-tumoral injection; once a day; for 17-21 days) can strongly inhibit tumor growth[1]. |
Alias | ADT007, ADT 007 |
Molecular Weight | 449.47 |
Formula | C26H24FNO5 |
Cas No. | 1945941-09-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.